133 results
8-K
EX-99.1
NVTAQ
Invitae Corp
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
belief that the acquisition will accelerate the evolution of its business and the nature and benefits of any such evolution; and Invitae’s beliefs … longer to realize than expected; risks related to integration and employee retention; the amount and nature of competition; and the other
risks set
8-K
NVTAQ
Invitae Corp
2 May 24
Entry into a Material Definitive Agreement
4:39pm
conditions (other than conditions that by their nature are to be satisfied at the closing) or (b) continuing with the transaction has been determined … the closing by the second business day following satisfaction or waiver of all closing conditions (other than conditions that by their nature
8-K
EX-10.2
NVTAQ
Invitae Corp
5 Apr 21
Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives
4:13pm
, and the parties hereto hereby waive any objection to the contrary.
SECTION 4.05. Binding Nature. The provisions of this Amendment shall be binding … OF ACTION, DEBTS, OBLIGATIONS, PROMISES, ACTS, AGREEMENTS, AND DAMAGES, OF WHATEVER KIND OR NATURE, WHETHER KNOWN OR UNKNOWN, SUSPECTED OR UNSUSPECTED
8-K
EX-10.1
4ij1xxfn1cvz0u3 eoeo
2 May 24
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-10.4
8szcx7o9h gpb2zyt2m8
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-99.1
ub1wjpx5w1bq4m
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
S-1
EX-10.3
hwg 0sp6b
9 Jan 15
IPO registration
12:00am
D
lfgv9so4
13 Apr 20
$52.37M in equity, sold $52.37M, 58 investors
12:00am
D
c7ywgx6ihy5clh td
15 Sep 10
$5.15M in equity, sold $3.64M, 10 investors
12:00am
8-K
EX-10.3
pavwvwn af
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm